Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adults With Major Depressive Disorder (MDD)
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo
used in addition to oral antidepressants in adults with MDD on improving symptoms of
depression.